# Study of Decompensated Alcoholic Cirrhosis Treatment by Stem Cells

> **NCT05155657** · PHASE1 · UNKNOWN · sponsor: **Yantai Yuhuangding Hospital** · enrollment: 36 (estimated)

## Conditions studied

- Alcoholic Cirrhosis

## Interventions

- **BIOLOGICAL:** Conventional therapy plus low dose UCMSCs treatment
- **BIOLOGICAL:** Conventional therapy plus medium dose UCMSCs treatment
- **BIOLOGICAL:** Conventional therapy plus high dose UCMSCs treatment

## Key facts

- **NCT ID:** NCT05155657
- **Lead sponsor:** Yantai Yuhuangding Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-06-13
- **Primary completion:** 2024-12-25
- **Final completion:** 2024-12-25
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2023-03-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05155657

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05155657, "Study of Decompensated Alcoholic Cirrhosis Treatment by Stem Cells". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05155657. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*